Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 29, 2026
Why Is Vertiv Holdings Co (VRT) Stock Down -10.04% Today?

Why Is Vertiv Holdings Co (VRT) Stock Down -10.04% Today?

Key Takeaways

  • Vertiv Holdings Co shares plunged 10.04% on Wednesday, extending a two-day selloff as the market reacted to a second-quarter revenue miss despite an earnings beat and raised full-year guidance.
  • The primary catalyst was Q2 revenue of $3.27 billion, which fell short of Wall Street's consensus estimate of approximately $3.38 billion, overshadowing stronger-than-expected adjusted EPS of $1.52.
  • Management attributed the revenue shortfall to "minor timing shifts" caused by temporary supply chain congestion and multi-phase project execution as AI infrastructure deployments grow larger and more complex.
  • The company raised its full-year 2026 revenue outlook to $13.8–$14.2 billion and adjusted EPS guidance to $6.65–$6.75, both ahead of analyst expectations, though this failed to stem the selloff.
  • The broader data-center and AI infrastructure sector faced selling pressure, and Vertiv's elevated valuation after a roughly 67% year-to-date rally left little room for disappointment.
  • Traders are now watching for signs that the revenue timing issues resolve in the second half, along with any commentary on order backlog trends and margin trajectory.

Opening Summary

VRT, officially Vertiv Holdings Co, is a global provider of critical digital infrastructure and continuity solutions for data centers, communication networks, and commercial and industrial environments. The company designs, manufactures, and services power management, thermal management, and IT infrastructure equipment that keeps high-density computing environments running continuously. On Wednesday, VRT shares tumbled 10.04%, closing the prior session at $269.56 before dropping to approximately $242.50 in intraday trading. The decline was driven by a second-quarter revenue miss that overshadowed an otherwise strong earnings report and an upward revision to the company's full-year guidance.

Q2 Earnings: EPS Beat, Revenue Miss

Vertiv reported second-quarter 2026 results before the market opened on Wednesday, delivering a mixed picture that ultimately disappointed Wall Street. The company posted adjusted earnings of $1.52 per share, comfortably ahead of the analyst consensus of $1.42 to $1.43. Net income surged to $497.8 million, or $1.27 per share, compared with $324.2 million, or $0.83 per share, in the year-ago quarter. Adjusted operating profit jumped 51% year over year, and adjusted operating margin expanded 410 basis points to 22.6%, reflecting strong operational efficiency and a favorable business mix.

However, revenue came in at $3.27 billion, up 24% from a year earlier but below the $3.37–$3.39 billion that analysts had projected. The organic revenue growth rate of 17.8% also fell short of expectations. For a stock that had rallied approximately 67% year-to-date through Tuesday's close, even a modest top-line miss was enough to trigger aggressive profit-taking.

Supply Chain Congestion and Project Timing

Vertiv's management attributed the revenue shortfall to "minor timing shifts" linked to temporary supply chain congestion and the increasingly phased nature of large AI infrastructure projects. As deployments grow more complex and capital-intensive, some revenue that might have been recognized in the second quarter is now expected to flow into the second half of the year. CEO Giordano Albertazzi characterized the quarter as reflecting "the compounding effect of years of deliberate investment in technology, capacity, and customer partnerships," and emphasized that underlying demand remains robust, with expanding customer pipelines and ongoing capacity investments worldwide.

While the explanation around timing is plausible, investors appeared unconvinced that the issue is purely transitory. The miss came at a moment when the market was already on edge about the pace and economics of AI-related capital spending, particularly after a sector-wide selloff the prior day that hit names tied to the AI data-center buildout.

Full-Year Guidance Raised, but Not Enough

In a move that would normally support the stock, Vertiv raised its full-year 2026 financial outlook. The company now expects adjusted earnings per share of $6.65 to $6.75, up from the prior range of $6.30 to $6.40 and above the consensus estimate of $6.48. Full-year revenue guidance was lifted to $13.8 billion to $14.2 billion, compared with the previous range of $13.5 billion to $14.0 billion and ahead of the $13.89 billion consensus. The company also forecast adjusted free cash flow of $2.4 billion to $2.6 billion for the year.

For the third quarter, Vertiv guided for adjusted EPS of $1.77 to $1.83 on revenue of $3.65 billion to $3.85 billion, broadly in line with analysts' expectations. Despite the upbeat forward guidance, the market focused squarely on the second-quarter revenue miss, treating the raised outlook as an acknowledgment that execution timelines remain uneven in an environment where hyperscalers are deploying infrastructure at unprecedented scale and speed.

Market Context and Trading Activity

The selloff in VRT did not occur in isolation. Tuesday's session saw a broader pullback across AI and data-center names, with AMD dropping over 5% and CORZ (Core Scientific) plunging nearly 9% after reporting a disappointing quarter. That sector-wide pressure set a cautious tone heading into Vertiv's own earnings release. When results confirmed that even the premier AI infrastructure suppliers can experience quarterly revenue volatility, the selling accelerated.

Wednesday's volume was elevated relative to recent sessions, reflecting the intensity of the post-earnings reaction. The stock sliced through its 50-day moving average of approximately $311 and its 200-day moving average near $276, both of which had previously served as key technical reference points. At roughly $242.50, VRT is now trading approximately 36% below its 52-week high of $379.94 reached in May 2026.

What Comes Next for VRT

Looking ahead, Vertiv's growth narrative remains anchored to the global expansion of AI data-center infrastructure. The company's project backlog reportedly exceeds $15 billion, and its recent manufacturing expansion in Malaysia underscores management's confidence in sustained demand across all regions. The raised full-year guidance suggests that the second-quarter revenue timing issues are expected to reverse in the second half of 2026.

Key risks include the potential for continued unevenness in large-project execution, ongoing supply chain constraints as deployments scale, and the broader question of whether AI infrastructure investment can maintain its current pace. With the stock now trading at a significantly lower valuation multiple than its recent peak, the focus will shift to the third-quarter report as the next major test of whether Vertiv can deliver the revenue acceleration implied by its guidance. Traders will also monitor macroeconomic conditions, interest rate expectations, and any signals from hyperscale customers about their capital spending plans.

Trending AI Robots

For traders seeking a data-driven edge amid volatile market conditions, Tickeron offers a curated selection of Trending AI Robots designed to adapt to evolving market dynamics. The platform features hundreds of AI-powered trading bots spanning thousands of tickers across multiple strategies, timeframes, and performance metrics. Only the strongest performers under current market conditions are showcased in the Trending AI Robots section, providing traders with actionable insights into which automated strategies are delivering results right now. Explore the Trending AI Robots page to discover bots that align with your trading approach.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VRT

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


VRT's RSI Oscillator recovers from oversold territory

The RSI Oscillator for VRT moved out of oversold territory on July 31, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In of the 18 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where VRT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VRT just turned positive on August 06, 2026. Looking at past instances where VRT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VRT advanced for three days, in of 354 cases, the price rose further within the following month. The odds of a continued upward trend are .

VRT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VRT as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

VRT moved below its 50-day moving average on July 01, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VRT entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VRT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.272) is normal, around the industry mean (8.806). P/E Ratio (62.256) is within average values for comparable stocks, (125.679). Projected Growth (PEG Ratio) (1.295) is also within normal values, averaging (1.368). Dividend Yield (0.001) settles around the average of (0.010) among similar stocks. P/S Ratio (9.398) is also within normal values, averaging (12.402).

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Plug Power (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL), GrafTech International Ltd (NYSE:EAF).

Industry description

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

Market Cap

The average market capitalization across the Electrical Products Industry is 5.92B. The market cap for tickers in the group ranges from 457 to 300.34B. CYATY holds the highest valuation in this group at 300.34B. The lowest valued company is NXUR at 457.

High and low price notable news

The average weekly price growth across all stocks in the Electrical Products Industry was 7%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -10%. OESX experienced the highest price growth at 77%, while ELPW experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Electrical Products Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was -18% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 71
Price Growth Rating: 63
SMR Rating: 84
Profit Risk Rating: 82
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
VRT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in the design, manufacturing, and servicing of critical digital infrastructure technology that powers, cools, deploys, secures and maintains electronics that process, store and transmit data.

Industry ElectricalProducts

Profile
Details
Industry
N/A
Address
505 North
Phone
+1 614 888-0246
Employees
27000
Web
https://www.vertiv.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.